Javascript must be enabled to continue!
Conformational Dynamics in Insulin Receptor Kinase Reveals a Type III Allosteric Pocket
View through CrossRef
Allosteric modulation of kinases is a promising approach for pharmacological intervention, particularly for designing selective kinase modulators. However, the structural information on allosteric pockets remains limited for most kinases in the human kinome. In this work, we present comprehensive characterization of a type III allosteric pocket in the insulin receptor kinase (IRK) by uncovering its structural features and conformational dynamics. Specifically, we used microsecond-scale atomistic molecular dynamics (MD) simulations to investigate apo and inhibitor-bound IRK structures. Our findings suggest that the type III allosteric site is a “back pocket” in IRK, sandwiched between the N-terminal and the C-terminal lobes, beneath the
α
C-helix and the
β
- sheets of the N-terminal lobe. It has a hydrophobic cleft composed of both aliphatic and aromatic non-polar residues and a charge center to facilitate electrostatic interactions. We explored the binding of an experimentally known IRK inhibitor to the newly discovered allosteric pocket. Our results indicate that the
α
C-helix adopts an “out” conformation stabilized by the inhibitor which promotes an inactive conformation of the kinase. Furthermore, we observed a helical intermediate formation in the activation loop and a stable “DFG-out” conformation in both inhibitor-bound and unbound states. Our results also suggest that the residue M1051 in IRK functions as a gatekeeper residue, essential for maintaining the structural integrity of the
α
C-helix and regulating the binding of the allosteric inhibitor. Our findings are relevant for developing allosteric IRK modulators and informing therapeutic strategies targeting proteins in the insulin receptor family.
Title: Conformational Dynamics in Insulin Receptor Kinase Reveals a Type III Allosteric Pocket
Description:
Allosteric modulation of kinases is a promising approach for pharmacological intervention, particularly for designing selective kinase modulators.
However, the structural information on allosteric pockets remains limited for most kinases in the human kinome.
In this work, we present comprehensive characterization of a type III allosteric pocket in the insulin receptor kinase (IRK) by uncovering its structural features and conformational dynamics.
Specifically, we used microsecond-scale atomistic molecular dynamics (MD) simulations to investigate apo and inhibitor-bound IRK structures.
Our findings suggest that the type III allosteric site is a “back pocket” in IRK, sandwiched between the N-terminal and the C-terminal lobes, beneath the
α
C-helix and the
β
- sheets of the N-terminal lobe.
It has a hydrophobic cleft composed of both aliphatic and aromatic non-polar residues and a charge center to facilitate electrostatic interactions.
We explored the binding of an experimentally known IRK inhibitor to the newly discovered allosteric pocket.
Our results indicate that the
α
C-helix adopts an “out” conformation stabilized by the inhibitor which promotes an inactive conformation of the kinase.
Furthermore, we observed a helical intermediate formation in the activation loop and a stable “DFG-out” conformation in both inhibitor-bound and unbound states.
Our results also suggest that the residue M1051 in IRK functions as a gatekeeper residue, essential for maintaining the structural integrity of the
α
C-helix and regulating the binding of the allosteric inhibitor.
Our findings are relevant for developing allosteric IRK modulators and informing therapeutic strategies targeting proteins in the insulin receptor family.
Related Results
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
(Invited) A Protein-Based Artificial Receptor for Insulin Sensing
Insulin is one of the most important hormones that controls the glucose level in blood. Therefore, the investigation of insulin is very important for the diabetic research. There h...
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients
Defects in insulin-receptor function have been associated with insulin-resistant states such as obesity and non-insulin-dependent diabetes mellitus (NIDDM). Several types of mutati...
Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) has been proposed as a counter-regulatory mechanism in insulin and cytokine signalling. Here we report that IRS-1 is ...
Trans-Allosteric Activation Releases Distinct Conformational Traps in Kinase Heterodimers
Trans-Allosteric Activation Releases Distinct Conformational Traps in Kinase Heterodimers
ABSTRACT
Protein kinases function as dynamic, mechanically coupled nodes, yet the conformational drivers of multimeric activation remain unclear. Here, we present A...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
Insulin Lispro: Its Role in the Treatment of Diabetes Mellitus
OBJECTIVE:
To introduce a rapid-acting human insulin analog, insulin lispro; to review its pharmacology, therapeutics, pharmacokinetics, dosing guidelines, adve...
Review on allosteric modulators of dopamine receptors so far
Review on allosteric modulators of dopamine receptors so far
AbstractBackgroundContemporary research is predominantly directed towards allosteric modulators, a class of compounds designed to interact with specific sites distinct from the ort...
Structural Models for a Series of Allosteric Inhibitors of IGF1R Kinase
Structural Models for a Series of Allosteric Inhibitors of IGF1R Kinase
Abstract
The allosteric inhibition of Insulin-like Growth Factor Receptor 1 Kinase (IGF1RK) is a potential strategy to overcome selectivity barriers in targeting re...

